passionate about supporting clinicians to improve patient outcomes and save lives

Thank you

We appreciate your interest in MAK-SYSTEM, a pioneer in healthcare software. Your inquiry is important to us, and we are dedicated to providing you with the highest level of service and expertise.

Thank you for your interest.
One of our team will be in touch very soon.

Latest news

MAK-SYSTEM announces strategic partnership with Northern Ireland Blood Transfusion Service

May 22, 2024

MAK-SYSTEM announces strategic partnership with Northern Ireland Blood Transfusion Service of “vein to vein” management from donor to recipient. MAK-SYSTEM is proud to be the partner of Northern Ireland Blood Transfusion Service to deliver safe, compliant and efficient blood management to patients, donors and clinicians. The partnership was announced by NI Health Minister Robin Swann … Read more

Read More

New Zealand Blood Service goes live on MAK.care!

February 15, 2024

MAK-SYSTEM’s innovative MAK.care service successfully went live at New Zealand Blood Service on February 11th 2024. MAK.care is the first Global Platform for blood and biologics, delivered as a service.  New Zealand Blood Service now has full end to end automation of the nationwide vein-to vein operations from blood donation to transfusion, securely managed in the cloud by MAK-SYSTEM on … Read more

Read More

eProgesa is now cleared under the 510(k) process, including for cloud hosting with MAK.Care

November 14, 2023

We are thrilled to share our BECS, eProgesa, is now 510k cleared from the FDA, including for cloud hosting with our MAK.Care service.! On 3rd November FDA informed us that our blood establishment computer system ePROGESA v5.0.3, is cleared under the 510(k) regulatory pathway and can be promoted and sold in the U.S. This 510(k) … Read more

Read More

Cosmas, the digital platform for Tissue, Stem Cell and Gene Therapies is CE-marked and registered for the EU market

November 7, 2023

We’re thrilled to announce that COSMAS, our new digital platform for Tissue, Stem Cell & Gene Therapies is CE-marked and registered for the EU market! COSMAS is now a CE-marked In Vitro Diagnostic medical device and can be sold in the European Union as of November 1st. Our COSMAS team and Quality & regulatory team … Read more

Read More

We collaborate with clients to deliver innovative technologies that address their digital healthcare needs today, stay ahead of future demand, and evolve in the face of challenges.